El interés en corto de Cellnex Telecom da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Cellnex Telecom. Los datos de interés en corto se actualizan cada dos semanas.

Cellnex Telecom (OTC:CLLNY) Bolsa, Informe de interés en corto

Cellnex owns and operates more than 100,000 wireless towers in Europe, resulting from continued M&A activity since its initial public offering in 2015. It has acquired towers from several European mobile network operators, including Telefonica, Iliad, CK Hutchison, Bouygues, and Altice. Cellnex is present in more than 10 European countries as of March 2023, including France, Italy, Spain, Poland, the United Kingdom, Switzerland, and Portugal. Cellnex's strategy is to acquire portfolios from MNOs and lease the towers back to them through long-term contracts, which provide high cash flow visibility and inflation protection.

ACSAY

ACXIF

CLLNY

REPYY

El BCE reducirá los tipos de interés otra vez en 2024. Descubre las posibles consecuencias para el euro y para estas empresas cotizadas.

El BCE reducirá tipos de interés en medio de incertidumbre económica europea

Acciones de Cellnex muestran un potencial alcista del 26%, lo que podría atraer a los inversores interesados en su crecimiento.

Acciones de Cellnex desafían expectativas: Divergencia entre acciones y bonos intriga al mercado

ANYYY

ENGGY

IMQCF

MRPRF

RDEIY

¿Cuáles son las empresas del Ibex que han logrado récords de ventas y beneficios en 2024 a pesar de los desafíos económicos? Descúbrelo aquí.

Estas acciones no financieras del Ibex baten récords de beneficios en 2024

CELLNEX TELECOM UNSP/ADR by Cellnex Telecom SA

Cellnex Telecom SA

Inflation has everyone talking, and the soaring housing cost is at the center of the conversation. It's not just a hot headline topic – <a href="https://www.benzinga.com/startups/24/10/41197078/hes-just-not-very-serious-says-kamala-harris-you-dont-just-throw-around-the-idea-of-tariffs-across-t">Kamala Harris</a> and Donald Trump have made it a major point in their 2024 presidential campaigns. Both Harris and Trump say they've got solutions, but not all ideas will hit the mark.
Harris, for example, is proposing direct help for first-time homebuyers. She wants to provide up to $25,000 in down-payment assistance, plus a $10,000 tax credit. However, there's a catch: whenever you throw money into a competitive housing market, it can drive prices up even further.&nbsp;
Don't Miss:
<ul>
<li>Beating the market through ethical real estate investing' — t<a href="https://www.benzinga.com/money/invest-with-roots">his platform aims to give tenants equity in the homes they live in while scoring 17.17% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
</ul>
Experts who spoke to ABC cited past programs in which the government helped push prices higher, benefiting sellers more than buyers.
Carla Krolage, an economist, highlighted a similar situation in Bavaria, Germany. A subsidy program there led to a price jump of about 10,000 euros per home. Harris's plan could have a similar effect, with home prices climbing rather than falling. Ed Pinto from the American Enterprise Institute voiced concerns that the $25,000 grant might raise home costs across the board, defeating the purpose of the assistance.
See Also: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
Still, Harris's focus on affordability and supply hasn't been seen in decades. David Dworkin of the National Housing Conference noted that her campaign's comprehensive housing plan is a sign that the crisis is being taken seriously. He also dismissed fears of skyrocketing prices, saying that combining down-payment assistance with investments in housing supply could avoid inflation.
Harris is also pushing for tax incentives for builders, which she believes will add three million new homes to the market. These incentives target starter homes and affordable rental units.&nbsp;
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
Such measures aren't entirely new; there's already a tax credit for developers under the Low-Income Housing Tax Credit (LIHTC), which has existed since 1986. While helpful, past reports show the program has become less efficient over time, producing fewer homes at a greater cost.
Trump, on the other hand, has a different approach. He wants to ban undocumented immigrants from getting mortgages, a move he says would cool the housing market. While<a href="https://www.benzinga.com/real-estate/24/09/40939943/elon-musk-mark-zuckerberg-and-jay-z-take-out-mortgages-despite-their-billion-dollar-fortunes-heres-w"> home loans</a> for undocumented immigrants are rare, Trump's proposal could also affect construction workers.&nbsp;
Trending: These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a>
With nearly 20% of U.S. construction labor made up of immigrants, many of whom are undocumented, restricting this workforce could lead to labor shortages and higher building costs. That would make meeting the country's growing housing demand even harder.
Another Trump plan involves loosening zoning laws, which he blames for slowing down construction and inflating costs. He argues that environmental regulations and complex permitting processes are holding builders back.
&nbsp;It's true that some cities, like Minneapolis, have already made moves to end single-family zoning to create more housing, but local resistance remains a challenge. Homeowners often push back on plans for denser, more affordable developments, wanting to protect their property values.
Read Next:
<ul>
<li>Can you guess which type of investments Morgan Stanley says will reach $2.7 trillion by 2027?<a href="https://www.benzinga.com/money/percent"> It even offers up to 20% APY potential to accredited investors up to $300 back in bonus for new users.</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>

Real Estate

Trump and Harris Reveal Their Game Plans to Tackle Skyrocketing Housing Prices – Here's What Has Worked Before and What Might Now

Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) will release earnings results for its third quarter, after the <a href="https://www.benzinga.com/quote/DPZ/earnings">closing bell on Thursday, Oct. 10</a>.
Analysts expect the Ann Arbor, Michigan-based company to report quarterly earnings at $3.65 per share, down from $4.18 per share in the year-ago period. Domino&#8217;s projects to report revenue of $1.1 billion for the quarter, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 18, the company reported second-quarter FY24 sales growth of 7.1% year-on-year to $1.097 billion, missing the analyst consensus estimate of $1.103 billion.
Domino&#8217;s shares gained 0.3% to close at $411.15 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5df37c17bffdfc0001d738fc/brian-mullan">Piper Sandler analyst Brian Mullan</a> maintained a Neutral rating and cut the price target from $436 to $429 on Oct. 7. This analyst has an accuracy rate of 78%.</li>
<li>Wedbush analyst Nick Setyan maintained an Outperform rating and slashed the price target from $510 to $470 on Oct. 4. This analyst has an accuracy rate of 71%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591c7409290fa70001b157ca/gregory-francfort">Guggenheim analyst Gregory Francfort</a> maintained a Neutral rating and decreased the price target from $485 to $460 on Sept. 26. This analyst has an accuracy rate of 71%.</li>
<li>JP Morgan analyst John Ivankoe maintained a Neutral rating and boosted the price target from $450 to $470 on Sept. 16. This analyst has an accuracy rate of 72%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58b05502b85e93000174c0ed/andrew-charles">TD Cowen analyst Andrew Charles</a> maintained a Buy rating and slashed the price target from $520 to $475 on Sept. 16. This analyst has an accuracy rate of 73%.</li>
</ul>
Considering buying DPZ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09032203/image-54-1024x495.png" alt="" class="wp-image-587028" style="width:621px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09032203/image-54-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09032203/image-54-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09032203/image-54-768x371.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09032203/image-54.png 1386w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

Domino's Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Loop Capital analyst Laura Champine upgraded the rating for The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) from Hold to Buy and raised the price target from $360 to $460. Home Depot shares closed at $414.18 on Tuesday. <a href="https://www.benzinga.com/quote/HD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Devin Ryan upgraded Raymond James Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) from Market Perform to Market Outperform and announced a $146 price target. Raymond James Finl shares closed at $124.90 on Tuesday. <a href="https://www.benzinga.com/quote/RJF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sheila Kahyaoglu upgraded the rating for Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) from Underperform to Hold and raised the price target from $24 to $32. Southwest shares settled at $30.67 on Tuesday. <a href="https://www.benzinga.com/quote/LUV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst James Faucette upgraded Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Underweight to Equal-Weight and raised the price target from $20 to $37. Affirm shares closed at $41.15 on Tuesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst James Hardiman upgraded the rating for Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) from Neutral to Buy and boosted the price target from $20 to $30. Norwegian Cruise shares closed at $20.80 on Tuesday. <a href="https://www.benzinga.com/quote/NCLH/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying HD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="523" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09094407/image-64-1024x523.png" alt="" class="wp-image-587760" style="width:656px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09094407/image-64-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09094407/image-64-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09094407/image-64-768x392.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09094407/image-64.png 1305w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>

Upgrades

AFRM

NCLH

This Home Depot Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.35% to 42,226.68 while the NASDAQ fell 0.20% to 18,146.90. The S&amp;P 500 also rose, gaining, 0.03% to 5,752.58.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41249094/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q3-earnings">How To Earn $500 A Month From JPMorgan Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares jumped by 0.5% on Wednesday.
In trading on Wednesday, communication services shares fell by 0.9%.
Top Headline
Helen Of Troy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) reported better-than-expected second-quarter results, reaffirming its FY25 sales and EPS outlook.
The company reported a second-quarter sales decline of 3.5% year-over-year to $474.221 million, beating the analyst consensus of $458.237 million. Adjusted EPS declined 34.1% YoY to $1.21, beating the consensus estimate of $1.04.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Momentus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares shot up 91% to $0.7966 after the company announced a NASA contract to provide launch services for future agency missions.</li>
<li>Shares of Banzai International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) got a boost, surging 80% to $4.9699 after the company announced strategic business initiatives to improve net income.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) shares were also up, gaining 38% to $1.65 after the company announced the pricing of an approximately $110 million private placement financing.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sacks Parente Golf, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares dropped 46% to $1.96 after gaining 35% after the company announced a $732K public offering of 366,000 shares of common stock for general corporate and working capital needs.</li>
<li>Shares of BAIYU Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYU#NASDAQ">BYU</a>) were down 43% to $0.5712.</li>
<li>Alternus Clean Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALCE#NASDAQ">ALCE</a>) was down, falling 37% to $0.0903 after the company announced a 1-for-25 reverse stock split as part of its Nasdaq compliance plan.</li>
</ul>
Commodities In commodity news, oil traded down 2.2% to $71.97 while gold traded down 0.3% at $2,627.90.
Silver traded up 0.2% to $30.645 on Wednesday, while copper fell 1.6% to $4.3870.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.3%, Germany's DAX gained 0.5% and France's CAC 40 rose 0.3%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 rose 0.4%.
Germany&#8217;s trade surplus increased to EUR 22.5 billion in August versus a revised EUR 16.9 billion in the prior month, topping market estimates of EUR 18.4 billion.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.87%, Hong Kong's Hang Seng Index dipping 1.38%, China's Shanghai Composite Index falling 6.62% and India's BSE Sensex dipping 0.21%.
Japan's machine tool orders declined 6.5% year-over-year to JPY 125,297 million in September compared to a 3.5% decline in the prior month, while the Reuters Tankan sentiment index for manufacturers climbed to +7 in October versus +4 in September. The Reserve Bank of India maintained its benchmark policy repo rate at 6.5% during October meeting.
Economics
U.S. mortgage applications declined by 5.1% from the previous week during the first week of October, compared to a 1.3% drop in the prior week.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">Jim Cramer Says He&#8217;s Buying &#8216;Some Target,&#8217; But Dismisses SoundHound AI As &#8216;Meme Stock</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">&#8216;</a></li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">&nbsp;</a>

Equities

Eurozone

Commodities

ALCE

BNZI

HELE

MNTS

SPGC

Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results

Rumors

IPOs

KinderCare Learning Companies IPO Indicating $25-$26/Share; IPO Priced At $24/Share On 24M Shares

<a href="https://www.beyondmeat.com/en-US/whats-new/mcdonald-s-france-launches-veggie-mcplant-nuggets" title="https://www.beyondmeat.com/en-US/whats-new/mcdonald-s-france-launches-veggie-mcplant-nuggets">https://www.beyondmeat.com/en-US/whats-new/mcdonald-s-france-launches-veggie-mcplant-nuggets</a>

BYND

Reported October 8: 'MCDONALD'S FRANCE LAUNCHES VEGGIE MCPLANT NUGGETS' - Beyond Meat

On Wednesday, Viking Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) released data from the Phase&nbsp;1b trial of VK0214, a novel small molecule agonist of the thyroid hormone receptor beta (TRβ), in patients with X-linked <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41246671/viking-therapeutics-announces-results-from-phase-1b-clinical-trial-of-vk0214-in-patients-with-x-al" rel="noreferrer noopener">adrenoleukodystrophy (X-ALD)</a>.&nbsp;
X-linked adrenoleukodystrophy is&nbsp;a genetic disorder that mainly affects the nervous system and the adrenal glands, which are located on top of each kidney.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39966690/viking-therapeutics-stock-surges-as-company-advances-weight-loss-drug-to-late-stage-trial-what-inves" rel="noreferrer noopener">Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know</a>.
Results showed VK0214 to be safe and well-tolerated following once-daily dosing over the 28-day study period.
In addition, plasma levels of very long-chain fatty acids (VLCFAs) and other lipids were significantly reduced compared to placebo.
VLCFAs are considered biomarkers of disease in patients with X-ALD.&nbsp; Treatment with VK0214 resulted in significant reductions in mean VLCFA levels at both doses evaluated, 20 mg/day and 40 mg/day, compared to placebo.
Cohorts receiving VK0214 demonstrated reductions in mean plasma levels of the 26 carbon lysophosphatidyl choline (C26:0-LPC) derivative, a key diagnostic marker.&nbsp;
A 14.8% reduction was observed in the 40 mg cohort (p=0.0105) and a reduction of 8.4% in the 20 mg cohort (p=0.0427). In addition to VLCFA changes, subjects who received VK0214 demonstrated reductions in other plasma lipids.
Mean reductions relative to baseline and placebo were observed for low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (ApoB), and lipoprotein (a) [Lp(a)] following 28 days of treatment.&nbsp;
Treatment-emergent adverse events were reported as mild to moderate. Gastrointestinal adverse events were slightly higher among placebo subjects (33%) compared with VK0214-treated subjects (11%).
William Blair highlights that the positive progress of VK0214 provides investors with additional opportunities beyond Viking's existing programs, including the subcutaneous and oral formulations of VK2735 for obesity, VK2809 for metabolic-dysfunction-associated steatohepatitis (MASH), and its preclinical amylin program, which is expected to enter clinical trials next year.
Since the analyst believes most investors have yet to factor in the potential revenue from VK0214, its continued successful development could offer an upside to current projections. Moreover, the focus on treating an orphan disease broadens Viking's potential revenue streams by expanding from the larger obesity and MASH markets into the rare disease space.
Price Action: VKTX stock is down 2.67% at $64.90 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41249524/honda-recalls-1-7m-vehicles-over-steering-gearbox-defect" target="_blank" rel="noreferrer noopener">Honda Recalls 1.7M Vehicles Over Steering Gearbox Defect</a>.</li>
</ul>

Analyst Color

Biotech

Health Care

General

VKTX

Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams

Stephens &amp; Co. analyst Scott Fidel reiterates Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) with a Equal-Weight and maintains $250 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target

Oppenheimer analyst Leland Gershell maintains Immunovant (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMVT#NASDAQ">IMVT</a>) with a Outperform and raises the price target from $47 to $53.

IMVT

Oppenheimer Maintains Outperform on Immunovant, Raises Price Target to $53

Wells Fargo analyst Michael Brown upgrades LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) from Equal-Weight to Overweight and raises the price target from $235 to $285.

LPLA

Wells Fargo Upgrades LPL Finl Hldgs to Overweight, Raises Price Target to $285

Stephens &amp; Co. analyst Scott Fidel reiterates Pennant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNTG#NASDAQ">PNTG</a>) with a Overweight and maintains $40 price target.

PNTG

Stephens & Co. Reiterates Overweight on Pennant Gr, Maintains $40 Price Target

Seaport Global analyst Sonny Randhawa initiates coverage on AFC Gamma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) with a Buy rating and announces Price Target of $13.

Initiation

AFCG

Seaport Global Initiates Coverage On AFC Gamma with Buy Rating, Announces Price Target of $13

AMZN

RIVN

Amazon To Deploy 1,000 Electric Delivery Vans From Rivian With Vision-Assisted Package Retrieval By Early 2025; To Use Lights Within Trucks To Guide Deliverers To Correct Packages

Amazon Adds More AI Powered Shopping Guides On Main Site; Says System Can Help Users Choose Products From New Categories

Citigroup analyst Ariel Rosa initiates coverage on Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) with a Buy rating and announces Price Target of $294.

Citigroup Initiates Coverage On Norfolk Southern with Buy Rating, Announces Price Target of $294

BMO Capital analyst Brian Pitz reiterates Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Outperform and lowers the price target from $222 to $215.

GOOG

GOOGL

BMO Capital Reiterates Outperform on Alphabet, Lowers Price Target to $215

Investment firm VanEck launched a $30 million early-stage fund focused on fintech, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40752428/crypto-set-to-dominate-ai-payments-bernstein-says">digital assets and AI startups.</a>
What Happened: The firm <a href="https://www.globenewswire.com/news-release/2024/10/09/2960588/0/en/VanEck-Launches-30M-Fund-to-Support-Innovation-in-Fintech-Crypto-and-AI.html">announced</a> on Wednesday that the fund, VanEck Ventures, will target pre-seed and seed-stage companies. 
Jan van Eck, CEO of VanEck and a keynote speaker at Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19, emphasized the company&#8217;s history of recognizing transformative opportunities, stating, &#8220;From pioneering an approach to gold investing in 1968 to recognizing the disruptive potential of Bitcoin in 2017, embracing a long-term view on transformative opportunities has always been part of our investment philosophy.&#8221;
VanEck Ventures will be led by Wyatt Lonergan and Juan Lopez, both experienced investors previously heading Circle Ventures, the venture arm of (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) issuer Circle. 
Their expertise, combined with VanEck&#8217;s reputation in asset management, positions the fund as a valuable partner for innovative startups.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
The fund&#8217;s investment strategy focuses on category-defining founders leveraging emerging technologies like blockchain and large language models. Key investment themes include <a href="https://www.benzinga.com/topic/tokenization">tokenized assets</a>, internet-native financial marketplaces and next-generation payment systems built on stablecoins and tokenized capital markets.
Wyatt Lonergan, General Partner at VanEck Ventures, highlighted three core inflection points shaping their investment thesis: &#8220;stablecoins emerging as an open-source banking layer, the commoditization of blockspace and AI breakthroughs.&#8221; He added that the convergence of these factors is creating &#8220;unprecedented opportunities for globally connected, user-centric financial experiences.&#8221;
The fund plans to make 25 to 35 investments, with check sizes ranging from $500,000 to $1 million. It has already made four undisclosed investments. Juan Lopez, also a general partner, noted the exciting timing for blockchain utility, saying, &#8220;As several on-chain utilities, focused on programmability and compliance, come to market with growing regulatory clarity, it&#8217;s never been a more exciting time to build.&#8221;
What's Next:&nbsp;VanEck CEO Jan Van Eck will speak at the upcoming Benzinga&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41053101/maxine-waters-says-crypto-is-inevitable-other-countries-are-way-ahead-of-the-united-states">Maxine Waters Says &#8216;Crypto Is Inevitable,&#8217; Other Countries Are &#8216;Way Ahead&#8217; Of The United States</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Startups

$USDC

VanEck Launches $30M Early-Stage Fund For Digital Assets, AI Startups

Stephens &amp; Co. analyst Jeff Garro maintains Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) with a Overweight and lowers the price target from $10 to $8.

ACCD

Stephens & Co. Maintains Overweight on Accolade, Lowers Price Target to $8

BMO Capital analyst Brian Quast maintains Aris Mining (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#TSX">ARIS</a>) with a Outperform and lowers the price target from C$10 to C$9.

TSX:ARIS

BMO Capital Maintains Outperform on Aris Mining, Lowers Price Target to C$9

Citigroup analyst Ariel Rosa initiates coverage on Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) with a Neutral rating and announces Price Target of $55.

Comments

Cellnex Telecom

Interés en corto

Cellnex Telecom (OTC:CLLNY) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL